Atypical forms of CAPS were particularly prevalent in patients with the K829T, Y859C, Y859H, and R918Q variants of NLRP3, with 94.1% (32/34) of hearing loss and only 30.7% (8/26) of skin manifestations. This evidence concerns the gene NLRP3 and hearing loss disorder.